BMT Stock Overview
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Beamtree Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.17 |
| 52 Week High | AU$0.33 |
| 52 Week Low | AU$0.17 |
| Beta | 1.75 |
| 1 Month Change | -19.05% |
| 3 Month Change | -20.93% |
| 1 Year Change | -42.37% |
| 3 Year Change | -59.52% |
| 5 Year Change | n/a |
| Change since IPO | -5.56% |
Recent News & Updates
Recent updates
Beamtree Holdings Limited (ASX:BMT) Might Not Be As Mispriced As It Looks
Jul 27
Is Now The Time To Look At Buying Beamtree Holdings Limited (ASX:BMT)?
Apr 05Estimating The Intrinsic Value Of Beamtree Holdings Limited (ASX:BMT)
Feb 06A Look At The Fair Value Of PKS Holdings Limited (ASX:PKS)
Feb 05
Can PKS Holdings Limited (ASX:PKS) Improve Its Returns?
Jan 01If You Had Bought PKS Holdings (ASX:PKS) Stock A Year Ago, You Could Pocket A 115% Gain Today
Nov 23Shareholder Returns
| BMT | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | -3.0% |
| 1Y | -42.4% | 52.4% | 3.9% |
Return vs Industry: BMT underperformed the Australian Healthcare Services industry which returned 52.4% over the past year.
Return vs Market: BMT underperformed the Australian Market which returned 3.9% over the past year.
Price Volatility
| BMT volatility | |
|---|---|
| BMT Average Weekly Movement | 8.6% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: BMT's share price has been volatile over the past 3 months.
Volatility Over Time: BMT's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 95 | Tim Kelsey | beamtree.com.au |
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records.
Beamtree Holdings Limited Fundamentals Summary
| BMT fundamental statistics | |
|---|---|
| Market cap | AU$48.87m |
| Earnings (TTM) | -AU$5.68m |
| Revenue (TTM) | AU$25.22m |
1.9x
P/S Ratio-8.6x
P/E RatioIs BMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMT income statement (TTM) | |
|---|---|
| Revenue | AU$25.22m |
| Cost of Revenue | AU$21.89m |
| Gross Profit | AU$3.33m |
| Other Expenses | AU$9.01m |
| Earnings | -AU$5.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 13.19% |
| Net Profit Margin | -22.54% |
| Debt/Equity Ratio | 1.1% |
How did BMT perform over the long term?
See historical performance and comparison